Centro Peninsular de Investigacion S.C.P

Mérida, Yucatán 97000

0 studies enrolling now · 4 studies all time

What they study most

Lupus Erythematosus, Systemic, Systemic Lupus Erythematosus

Studies at this site

• Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study — Stopped early
• Study of VIB7734 for the Treatment of Moderate to Severely Active SLE — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early